2023
DOI: 10.3389/fpsyt.2023.1102258
|View full text |Cite
|
Sign up to set email alerts
|

Measuring resilience by cognitive diagnosis models and its prediction of 6-month quality of life in Be Resilient to Breast Cancer (BRBC)

Abstract: ObjectiveThe application of advanced Cognitive Diagnosis Models (CDMs) in the Patient Reported Outcome (PRO) is limited due to its complex statistics. This study was designed to measure resilience using CDMs and its prediction of 6-month Quality of Life (QoL) in breast cancer.MethodsA total of 492 patients were longitudinally enrolled from Be Resilient to Breast Cancer (BRBC) and administered with 10-item Resilience Scale Specific to Cancer (RS-SC-10) and Functional Assessment of Cancer Therapy-Breast (FACT-B)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 14 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…Fourth, the sample sizes of the training and validation cohorts are relatively small, and the prediction model should be validated in a larger population with different cancer diagnoses. Fifth, measurement errors were not taken into consideration to calculate the QoL outcomes, and item response theory could be tried to achieve a better estimation [47][48][49][50].…”
Section: Limitationsmentioning
confidence: 99%
“…Fourth, the sample sizes of the training and validation cohorts are relatively small, and the prediction model should be validated in a larger population with different cancer diagnoses. Fifth, measurement errors were not taken into consideration to calculate the QoL outcomes, and item response theory could be tried to achieve a better estimation [47][48][49][50].…”
Section: Limitationsmentioning
confidence: 99%
“…In addition, CDMs are also used in diagnosing physical health. Liang et al [82] employed G-DINA, in conjunction with constructed data and a Q-matrix, to predict six-month Quality of Life (QoL) in breast cancer. The results from CDMs provide valuable references for doctors to assess examinees' health conditions and support planning the treatments.…”
Section: Applications In Other Domainsmentioning
confidence: 99%